Che Ping Cheng | Translational Neuroscience | Best Researcher Award

Prof. Che Ping Cheng | Translational Neuroscience | Best Researcher Award

Prof. Che Ping Cheng, Wake Forest University School of Medicine, United States.

Dr. Che Ping Cheng, M.D., Ph.D., FAHA, is a distinguished cardiovascular physiologist and internal medicine specialist whose career has been dedicated to advancing the understanding of heart function and failure. From earning his medical degree in China to completing a Ph.D. in Physiology at Wayne State University, and later conducting pivotal postdoctoral research at Wake Forest School of Medicine, Dr. Cheng has consistently pursued excellence in science and education. His research on ventricular mechanics, volume loading, and heart failure has significantly influenced both experimental cardiology and clinical practice. Recognized as a Fellow of the American Heart Association, he is also a dedicated mentor, shaping the next generation of cardiovascular researchers through his academic leadership.

Profile

Scopus

 

🎓 Early Academic Pursuits

Dr. Che Ping Cheng’s journey into medicine and science began in Nanjing, China, where he earned his M.D. degree from Nanjing Railway Medical University in 1977. His early academic path reflected a deep interest in understanding the intricacies of human health, particularly in cardiovascular physiology. Driven by a desire to expand his knowledge and research capabilities, Dr. Cheng pursued his Ph.D. in Physiology at Wayne State University School of Medicine in Detroit, Michigan, completing his degree in 1986. Under the mentorship of Dr. Robert S. Shepard, his doctoral work focused on exploring the mechanisms of cardiovascular response to volume loading in a canine model with tricuspid valvulectomy, setting a strong foundation for his lifelong focus on heart function and disease mechanisms.

🩺 Professional Endeavors

Following his academic training, Dr. Cheng embarked on postdoctoral studies at the Bowman Gray School of Medicine (now part of Wake Forest School of Medicine), where he continued to cultivate his expertise in internal medicine and cardiovascular physiology. Between 1986 and 1988, he served as a Postdoctoral Fellow under the guidance of Dr. William C. Little. His research during this period focused on ventricular dynamics and the physiological factors affecting active ventricular filling, which would later inform his broader work on heart failure and cardiac function. Dr. Cheng has since remained at Wake Forest School of Medicine, where he is currently a distinguished member of the Section on Cardiovascular Medicine.

🧪 Contributions and Research Focus

Dr. Cheng’s career has been characterized by a deep commitment to advancing the understanding of cardiac hemodynamics, ventricular interaction, and heart failure mechanisms. His research has explored how ventricular function responds under altered physiological states, and how these responses inform disease progression and treatment strategies. His early animal model studies have provided critical insights into the interplay between structural and functional changes in the heart, especially in the context of diastolic dysfunction and volume overload conditions. Dr. Cheng has also made significant strides in translating these findings to clinical contexts, influencing how cardiologists approach diagnosis and therapy.

🏅 Accolades and Recognition

Throughout his career, Dr. Cheng has received considerable recognition for his scholarly contributions. He is a Fellow of the American Heart Association (FAHA), an honor that reflects his standing in the field of cardiovascular research and his commitment to scientific excellence. His work has earned the respect of colleagues and institutions alike, leading to numerous invitations to contribute to collaborative projects, serve on peer-review panels, and mentor future generations of cardiovascular researchers.

🌍 Impact and Influence

Dr. Cheng’s work has had a lasting impact on both experimental and clinical cardiology. By elucidating the mechanistic basis of ventricular dysfunction, he has helped shift paradigms in heart failure management, particularly in the areas of ventricular interdependence and preload responsiveness. His research findings are frequently cited in textbooks and high-impact journals, and they continue to inform guidelines for cardiac care and interventions. Through his work at Wake Forest and beyond, Dr. Cheng has played a pivotal role in bridging laboratory discoveries with bedside applications.

👨‍🏫 Legacy and Mentorship

As a respected mentor and educator, Dr. Cheng has dedicated a significant portion of his career to training medical students, residents, and postdoctoral fellows. His mentorship has influenced numerous emerging scholars in cardiovascular medicine, many of whom have gone on to successful academic and clinical careers. His guidance combines a rigorous scientific approach with a deep sense of responsibility to patient care and scientific integrity, shaping a legacy that extends well beyond his own research output.

🔬 Future Contributions and Vision

Looking ahead, Dr. Cheng remains committed to the advancement of cardiovascular research, with a continued focus on uncovering the cellular and mechanical determinants of heart disease. His vision includes fostering collaborative projects that integrate biomedical engineering, imaging, and computational modeling to further understand cardiac performance. With decades of experience and a forward-thinking approach, Dr. Cheng’s future contributions are poised to leave a lasting mark on the field of translational cardiovascular medicine.

Publication

  1. Title: Increased CaMKII activation and contrast changes of cardiac β1-and β3-Adrenergic signaling pathways in a humanized angiotensinogen model of hypertension
    Authors: Sun, Xiaoqiang; Cao, Jing; Chen, Zhe; Ferrario, Carlos M.; Cheng, Cheping
    Year: 2023
    Journal: Heliyon

 

  1. Title: Calmodulin-dependent protein kinase II activation promotes kidney mesangial expansion in streptozotocin-induced diabetic mice
    Authors: Mikhailov, Alexei V.; Liu, Yixi; Cheng, Hengjie; Lin, Jen Jar; Cheng, Cheping
    Year: 2022
    Journal: Heliyon

 

  1. Title: Chronic GPR30 agonist therapy causes restoration of normal cardiac functional performance in a male mouse model of progressive heart failure: Insights into cellular mechanisms
    Authors: Zhang, Xiaowei; Li, Tiankai; Cheng, Hengjie; Groban, Leanne; Cheng, Cheping
    Year: 2021
    Journal: Life Sciences

 

  1. Title: Chronic Ca2+/calmodulin-dependent protein Kinase II inhibition rescues advanced heart failure
    Authors: Liu, Yixi; Shao, Qun; Cheng, Hengjie; Zhao, David Xiao Ming; Cheng, Cheping
    Year: 2021
    Journal: Journal of Pharmacology and Experimental Therapeutics

 

  1. Title: The Angiotensin-(1–12)/Chymase axis as an alternate component of the tissue renin angiotensin system
    Authors: Ferrario, Carlos M.; Groban, Leanne; Wang, Hao; Sun, Xuming; Ahmad, Sarfaraz
    Year: 2021
    Journal: Molecular and Cellular Endocrinology

 

  1. Title: Reversal of angiotensin-(1–12)-caused positive modulation on left ventricular contractile performance in heart failure: Assessment by pressure-volume analysis
    Authors: Li, Tiankai; Zhang, Zhi; Zhang, Xiaowei; Ferrario, Carlos M.; Cheng, Cheping
    Year: 2020
    Journal: International Journal of Cardiology

 

  1. Title: Female Heart Health: Is GPER the Missing Link?
    Authors: Groban, Leanne; Tran, Q. K.; Ferrario, Carlos M.; Wang, Hao; Lindsey, Sarah H.
    Year: (Not specified, but likely 2020 or 2021)
    Journal: (Not specified)

 

🏁 Conclusion

Dr. Cheng’s legacy is one of intellectual rigor, clinical relevance, and mentorship. His work has not only deepened the scientific understanding of cardiac physiology but has also shaped modern approaches to diagnosing and managing heart failure. With a career spanning continents and disciplines, Dr. Cheng continues to be a guiding force in cardiovascular medicine, and his future contributions are anticipated to further advance the frontiers of heart research and patient care.

 

Handrean Soran | Clinical Neuroscience | Best Researcher Award

Prof. Handrean Soran | Clinical Neuroscience | Best Researcher Award

Prof. Handrean Soran,  Manchester University NHS Foundation Trust, United Kingdom.

Dr. Handrean Soran is a distinguished British endocrinologist and researcher with expertise in diabetes, endocrinology, and cardiovascular diseases. His academic journey began in Iraq and advanced through the UK, where he earned prestigious medical qualifications, including an MD in Medicine and MSc in Diabetes and Endocrinology. Throughout his career, Dr. Soran has contributed significantly to research on the relationship between diabetes and cardiovascular health, publishing extensively in high-impact journals like The New England Journal of Medicine and Lancet. His work has garnered global recognition, including an H-index of 49 and numerous accolades, solidifying his position as a leader in his field.

Profile

Google Scholar

 

Early Academic Pursuits 📚

Handrean Soran’s academic journey began in the Kurdistan region of Iraq, where he completed his A-levels with an impressive score of 94.5% from Sulemani High School in 1985. His drive for knowledge led him to pursue his MBChB at Al-Mustansyria University in Baghdad, Iraq, graduating in 1990. This foundational education set the stage for a career dedicated to medical research and practice. After completing his medical degree, he pursued further specialized training in the UK, where he earned his MRCP from the Royal College of Physicians in Edinburgh in 1999, and later, an MSc in Diabetes and Endocrinology from the University of Liverpool in 2006. These early academic milestones laid the foundation for his later expertise in endocrinology and diabetes, fields that would define his career.

Professional Endeavors 🏥

Dr. Handrean Soran’s professional journey is marked by a dedication to medicine, particularly in the fields of endocrinology and diabetes. He has held significant roles in prestigious institutions, with his current position in the Department of Diabetes, Endocrinology, and Metabolism at Manchester University Hospitals NHS Foundation Trust. His medical career was further enhanced by his qualifications as a Fellow of the Royal College of Physicians (FRCP) from both Glasgow and Edinburgh. Throughout his career, Dr. Soran has worked on developing innovative approaches in clinical care and research, constantly striving to improve patient outcomes and advancing medical knowledge.

Contributions and Research Focus 🔬

Dr. Soran’s research focus primarily centers on diabetes, endocrinology, and cardiovascular health, specifically the interplay between metabolic disorders and heart disease. His research efforts have been integral to understanding the link between diabetes and cardiovascular risk, with a significant body of work examining the effects of treatments on these interconnected conditions. His contributions have been recognized through multiple high-impact publications in renowned journals such as the New England Journal of Medicine, Lancet, and European Heart Journal. With an H-index of 49 and over 130 citations, Dr. Soran’s work continues to shape the clinical landscape in these areas, driving further advancements in treatment protocols and therapeutic strategies for diabetes and cardiovascular diseases.

Accolades and Recognition 🏆

Dr. Soran’s career has been decorated with numerous accolades, affirming his status as a leader in his field. He achieved the prestigious title of Fellow of the Royal College of Physicians (FRCP) in both Edinburgh and Glasgow, a testament to his clinical expertise and contribution to medical science. His groundbreaking work in diabetes and cardiovascular research has earned him recognition not only from peers but also from major medical institutions. His publications in top-tier journals further highlight his academic prowess, solidifying his position as a key thought leader in the medical and academic communities.

Impact and Influence 🌍

Dr. Handrean Soran’s work extends beyond the realm of research publications; it has made a lasting impact on the clinical management of diabetes and cardiovascular diseases worldwide. His insights have contributed to shaping healthcare policies and clinical practices, particularly in the management of diabetic patients at high cardiovascular risk. Through his collaboration with the Division of Cardiovascular Sciences at the University of Manchester, he has fostered interdisciplinary approaches to solving complex medical challenges, advancing the integration of cardiovascular care with endocrinology. His work has influenced not only academic circles but also clinical practice, providing new directions for patient care.

Legacy and Future Contributions 🌱

As Dr. Soran continues his impactful work, his legacy is one of dedication to improving patient health outcomes and advancing the fields of endocrinology and diabetes. With a deep commitment to teaching and mentorship, Dr. Soran plays a pivotal role in training the next generation of doctors and researchers. His future contributions are poised to further explore the intricate relationship between metabolic disorders and cardiovascular health, addressing the growing global burden of these interconnected diseases. His work will undoubtedly continue to guide both clinical practice and future research in endocrinology, diabetes, and cardiovascular medicine, ensuring his ongoing influence in these critical areas.

Global Recognition and Influence 🌐

Dr. Soran’s influence reaches across borders, as evidenced by his extensive publication record and recognition within the global medical community. His research has not only enriched the scientific literature but also contributed to global health initiatives, particularly in the area of metabolic disorders and cardiovascular diseases. With collaborations spanning multiple continents, Dr. Soran is dedicated to improving health outcomes globally, offering expert insights into the prevention and management of diabetes and heart disease. His role in shaping clinical guidelines and his participation in international research collaborations further amplify his global impact.

Academic and Professional Leadership 🎓

In addition to his research contributions, Dr. Soran’s leadership within academia is profound. He holds multiple academic positions, including his affiliation with the University of Manchester, where he plays an integral role in advancing research within the Division of Cardiovascular Sciences. His leadership extends to mentoring young researchers and clinicians, helping to foster a new generation of experts in endocrinology and diabetes. Dr. Soran’s academic vision continues to drive progress in both education and research, making significant strides in improving how diabetes and cardiovascular diseases are understood and treated. His future work promises to leave a lasting mark on medical education and the advancement of scientific knowledge.

Publication

  • Cardiovascular efficacy and safety of bococizumab in high-risk patients
    Author: PM Ridker
    Year: 2017

 

  • Volanesorsen and triglyceride levels in familial chylomicronemia syndrome
    Author: JL Witztum
    Year: 2019

 

  • Triglyceride lowering with pemafibrate to reduce cardiovascular risk
    Author: A Das Pradhan
    Year: 2022

 

  • Diabetes dyslipidemia
    Author: JD Schofield
    Year: 2016

 

  • Lysosomal acid lipase deficiency–an under-recognized cause of dyslipidaemia and liver dysfunction
    Author: Ž Reiner
    Year: 2014

 

  • Obesity: a critical risk factor in the COVID‐19 pandemic
    Author: S Kwok
    Year: 2020

 

  • Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY …
    Author: KK Ray
    Year: 2019

 

  • Hypercholesterolaemia and its management
    Author: D Bhatnagar
    Year: 2008

 

  • Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies
    Author: B Williams
    Year: 2018

 

  • Long-term treatment with evolocumab added to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesterolaemia: an interim subset …
    Author: FJ Raal
    Year: 2017

 

Conclusion

Dr. Handrean Soran’s career is marked by profound contributions to medical science, particularly in the fields of diabetes and cardiovascular health. His groundbreaking research and clinical expertise have had a significant impact on both academic and healthcare practices worldwide. As a recognized leader in his field, Dr. Soran’s work continues to influence the management of metabolic and cardiovascular diseases, and his future contributions promise to further advance these critical areas of medical research and practice. His legacy is one of dedication, leadership, and a commitment to improving health outcomes globally.

 

Jin Yong Hong | Behavioral Neuroscience | Best Researcher Award

Assoc. Prof. Dr. Jin Yong Hong | Behavioral Neuroscience | Best Researcher Award

Assoc. Prof. Dr. Jin Yong Hong,  Yonsei University Wonju College of Medicine,  South Korea.

Dr. Jin Yong Hong, MD, PhD, is a distinguished neurologist and academic leader with a career grounded in excellence, innovation, and service. Beginning his medical education at Yonsei University, he steadily advanced through rigorous academic and clinical pathways to become an Associate Professor at Yonsei University Wonju College of Medicine. His focused expertise in movement disorders and dementia, enriched by both national and international research experience, especially at the University of Pennsylvania, highlights his dedication to solving complex neurological diseases. Through teaching, research, and clinical practice, he has significantly contributed to the growth of neuroscience and medical education in South Korea.

 

Profile

Google Scholar

Orcid

 

🎓 Early Academic Pursuits

Dr. Jin Yong Hong embarked on his journey in medicine with a deep commitment to academic excellence, beginning with his premedical studies at Yonsei University in Seoul from 2001 to 2003. He swiftly advanced through the rigorous medical curriculum, earning a Bachelor of Medical Science in 2007. Not content with just clinical practice, he pursued higher education with a Master of Medical Science completed in 2014 and culminated his scholarly journey with a Doctorate in Medical Science from the same esteemed institution in 2021. His academic path reflects a relentless pursuit of knowledge in the neurological sciences and a strong foundation in research methodology and clinical application.

🧠 Professional Endeavors in Neurology

Following his graduation, Dr. Hong immersed himself in hands-on clinical training, beginning with an internship and residency in Neurology at the renowned Severance Hospital of the Yonsei University Health System. This period, from 2007 to 2012, was marked by rigorous clinical immersion and specialization. His passion for neuroscience led him to pursue subspecialty training in Movement Disorders and Dementia, completing both clinical and research fellowships. Notably, he expanded his research exposure internationally through a postdoctoral fellowship at the University of Pennsylvania in the United States from 2022 to 2024, further enriching his expertise in neurodegenerative pathology and laboratory medicine.

🔬 Contributions and Research Focus

Dr. Hong’s research has consistently revolved around movement disorders and dementia, placing him at the forefront of understanding neurodegenerative diseases. His clinical experience, paired with extensive research work in both Korea and the United States, underscores his commitment to unraveling the complexities of disorders like Parkinson’s disease, Alzheimer’s disease, and related cognitive impairments. His interdisciplinary approach bridges clinical neurology with translational science, contributing significantly to advancing diagnostic and therapeutic strategies in the field.

🏥 Academic Leadership and Teaching

As an Associate Professor at the Department of Neurology, Yonsei University Wonju College of Medicine, Dr. Hong plays a vital role in shaping the next generation of neurologists. Since 2016, he has not only led clinical initiatives but also mentored students and junior faculty. His previous tenure as a Clinical Assistant Professor from 2014 to 2016 helped lay the groundwork for a collaborative and research-driven academic environment at the Wonju Severance Christian Hospital. His academic roles have helped blend clinical excellence with cutting-edge research in one of Korea’s premier medical institutions.

🏅 Accolades and Recognition

Dr. Hong’s excellence has been consistently recognized by peers and institutions alike. In 2014, he received the Academic Award for Highest Achievement from Yonsei University College of Medicine, marking him as a top-tier scholar among his peers. The same year, he was awarded a Fellowship by the Korean Movement Disorder Society, acknowledging his promising contributions to the field. Further cementing his role as a leading voice in neurological research, he was honored in 2021 with the JMD Article Award, reflecting the impact and relevance of his scholarly publications.

🌍 Impact and Influence in Neurological Science

With active memberships in the Korean Neurological Association, the Korean Movement Disorder Society, and the Korean Dementia Association, Dr. Hong maintains an influential presence within the scientific community. His cross-continental experience, especially through his postdoctoral work in the United States, has positioned him as a bridge between Eastern and Western neurological research paradigms. His publications and ongoing collaborations continue to influence both clinical practice and academic discourse, especially in the diagnosis and management of neurodegenerative conditions.

🌟 Legacy and Future Contributions

Looking ahead, Dr. Jin Yong Hong is poised to continue making groundbreaking contributions in the field of neurology. With a career marked by academic distinction, clinical expertise, and research innovation, he represents a model of holistic excellence in medicine. His future work is likely to delve deeper into translational neuroscience, aiming to develop practical solutions for patients suffering from movement and cognitive disorders. As a mentor, researcher, and clinician, Dr. Hong is building a legacy that will inspire and influence the medical community for years to come.

Publication

  • Neuroanatomical substrates of visual hallucinations in patients with non-demented Parkinson’s disease
    S Shin, JE Lee, JY Hong, MK Sunwoo, YH Sohn, PH Lee
    2012

 

  • Presynaptic dopamine depletion predicts levodopa-induced dyskinesia in de novo Parkinson disease
    JY Hong, JS Oh, I Lee, MK Sunwoo, JH Ham, JE Lee, YH Sohn, JS Kim, …
    2014

 

  • The MMSE and MoCA for screening cognitive impairment in less educated patients with Parkinson’s disease
    JI Kim, MK Sunwoo, YH Sohn, PH Lee, JY Hong
    2016

 

  • The burden of white matter hyperintensities is a predictor of progressive mild cognitive impairment in patients with Parkinson’s disease
    MK Sunwoo, S Jeon, JH Ham, JY Hong, JE Lee, JM Lee, YH Sohn, …
    2014

 

  • Cerebral microbleeds in patients with Parkinson’s disease
    JH Ham, H Yi, MK Sunwoo, JY Hong, YH Sohn, PH Lee
    2014

 

  • Subjective cognitive decline predicts future deterioration in cognitively normal patients with Parkinson’s disease
    JY Hong, MK Sunwoo, SJ Chung, JH Ham, JE Lee, YH Sohn, PH Lee
    2014

 

  • Clinical and biomarker characteristics according to clinical spectrum of Alzheimer’s disease (AD) in the validation cohort of Korean Brain Aging Study for the Early Diagnosis …
    J Hwang, JH Jeong, SJ Yoon, KW Park, EJ Kim, B Yoon, JW Jang, HJ Kim, …
    2019

 

  • Subjective cognitive complaints and objective cognitive impairment in Parkinson’s disease
    JY Hong, Y Lee, MK Sunwoo, YH Sohn, PH Lee
    2018

 

  • Neurocognitive and atrophic patterns in Parkinson’s disease based on subjective memory complaints
    JY Hong, JE Lee, YH Sohn, PH Lee
    2012

 

  • Telomere shortening reflecting physical aging is associated with cognitive decline and dementia conversion in mild cognitive impairment due to Alzheimer’s disease
    SH Koh, SH Choi, JH Jeong, JW Jang, KW Park, EJ Kim, HJ Kim, JY Hong, …
    2020

 

🧾 Conclusion

Dr. Hong’s journey illustrates the profound impact one dedicated individual can make within the scientific and medical communities. His legacy is already evident in his scholarly achievements, the students he mentors, and the patients he serves. As he continues to advance the understanding and treatment of neurological conditions, Dr. Hong remains a beacon of academic integrity, scientific rigor, and compassionate care. His future promises continued breakthroughs that will shape the field of neurology and bring hope to countless lives affected by neurodegenerative disorders.

EMRE MISIR | Cognitive Neuroscience | Young Scientist Award

Assist. Prof. Dr. EMRE MISIR | Cognitive Neuroscience | Young Scientist Award

Assist. Prof. Dr.  EMRE MISIR, Baskent University, Turkey.

Dr. Emre MISIR is a distinguished psychiatrist and neuroscience researcher, whose academic journey began at Adnan Menderes University and led to specialization in psychiatry at Dokuz Eylül University. His professional career includes serving as a Specialist Physician at Yozgat City Hospital before transitioning to an academic role at Başkent University Faculty of Medicine. Currently, he is pursuing a Ph.D. in Interdisciplinary Neuroscience at Ankara University, focusing on Theory of Mind in Obsessive-Compulsive Disorder (OCD). His outstanding exam scores, professional memberships, and active research contributions underscore his dedication to advancing psychiatry.

Profile

Orcid

Early Academic Pursuits 🎓

Born on July 16, 1989, in Şahinbey, Gaziantep, Turkey, Dr. Emre MISIR embarked on an academic journey rooted in a passion for medicine and mental health. He completed his medical education at Adnan Menderes University between 2006 and 2012, where his keen interest in the complexities of the human mind began to take shape. His dedication and academic excellence led him to pursue a specialization in psychiatry at Dokuz Eylül University Faculty of Medicine, where he trained extensively from 2012 to 2017.

Professional Endeavors 🏥

Following his specialization, Dr. MISIR served as a Specialist Physician at Yozgat City Hospital from 2017 to 2020, providing essential mental health care to diverse patient populations. In July 2020, he transitioned to Başkent University Faculty of Medicine, where he continued his professional practice before taking on a more academic role. By April 2020, his expertise and commitment to education earned him a Lecturer position at Başkent University, where he has been actively involved in mentoring young psychiatrists and medical students.

Contributions and Research Focus 🔬

With a profound interest in the intersection of psychiatry and neuroscience, Dr. MISIR has dedicated his research to understanding complex cognitive and psychological disorders. Currently pursuing a doctoral program in Interdisciplinary Neuroscience at Ankara University, his research explores the intricate mechanisms underlying obsessive-compulsive disorder (OCD). His thesis, titled “Theory of Mind in Patients with Obsessive-Compulsive Disorder: Relationship with Cognitive Functions, Overvalued Ideas, Insight, Schizotypal Personality Traits, and Other Clinical Characteristics,” under the supervision of Prof. Dr. Berna Binnur Kıvırcık Akdede, sheds light on the cognitive and neurobiological factors influencing psychiatric conditions.

Accolades and Recognition 🏅

Dr. MISIR’s commitment to academic excellence is reflected in his outstanding achievements in competitive examinations. His remarkable performance in the TUS Clinical Exam (Fall 2012) with a rank of 101, and his high ALES Numerical score of 88.58 demonstrate his academic rigor. Additionally, his proficiency in English, certified by a YÖKDİL score of 88.75, further amplifies his ability to contribute to international research and collaboration in psychiatry and neuroscience.

Impact and Influence 🌍

Beyond clinical practice and academia, Dr. MISIR is an active member of key professional organizations, including the Turkish Psychiatric Association, the Cognitive Behavioral Psychotherapy Association, and the Clinical Neuropsychopharmacology Association, where he serves as the Treasurer. His contributions to these organizations reflect his dedication to advancing psychiatric research and improving mental health treatments in Turkey and beyond. Through his engagement in professional networks, he has been instrumental in fostering interdisciplinary collaboration and promoting evidence-based psychiatric practices.

Legacy and Future Contributions 🚀

As a psychiatrist, researcher, and educator, Dr. MISIR continues to push the boundaries of neuroscience and psychiatric research. His work not only enhances the understanding of cognitive disorders but also paves the way for more effective diagnostic and therapeutic approaches. With his ongoing doctoral research and contributions to academic literature, he aspires to shape the future of psychiatric treatment, integrating neurobiological insights with clinical practice. His unwavering dedication to mental health and neuroscience ensures that his influence will extend beyond his current academic and clinical roles, leaving a lasting impact on the field.

Publication

  • Clinical Characteristics of Cognitive Subgroups of Obsessive Compulsive Disorder

    • Authors: Emre Mısır, Raşit Tükel, Berna Binnur Akdede, Emre Bora

    • Year: 2025

 

  • Validity and Reliability Study of the Turkish Form of the 4th Version of the Mental Illness: Clinicians’ Attitudes (MICA) Scale

    • Authors: Emre Mısır, Yasemin Hosgören Alıcı, Zeynep Bozkurt, Hüseyin Batuhan Elhan

    • Year: 2024

 

  • Functional connectivity in rumination: a systematic review of magnetic resonance imaging studies

    • Authors: Emre Mısır, Yasemin Hoşgören Alıcı, Orhan Murat Kocak

    • Year: 2023

 

  • Synaptic dysfunction in schizophrenia

    • Authors: Emre Mısır, Güvem Gümüş Akay

    • Year: 2023

 

  • The effects of catechol‐O‐methyltransferase single nucleotide polymorphisms on positive and negative symptoms of schizophrenia: A systematic review and meta‐analysis

    • Authors: Emre Misir, Mutlu Muhammed Ozbek, Eren Halac, Serkan Turan, Gokce Elif Alkas, Remzi Ogulcan Ciray, Cagatay Ermis

    • Year: 2022

 

  • DSM-5 Anksiyöz Distres Değerlendirme Ölçeği Türkçe Formunun Major Depresif Bozukluk için Geçerlilik ve Güvenilirlik Çalışması

    • Authors: Emre Mısır

    • Year: 2020

 

  • Reliability and validity of the Turkish Version of DSM-5 Anxious Distress Rating Scale for major depressive disorder

    • Authors: Misir, Emre; Hacimusalar, Yunus

    • Year: 2020

 

  • THE BRIEF RESIDENT WELLNESS PROFILE: VALIDITY AND RELIABILITY OF TURKISH VERSION

    • Authors: Misir, Gamze Akyol; Balik, Gurcan; Misir, Emre; Kartal, Mehtap

    • Year: 2020

 

  • The concept of schizotypy and schizotypal personality disorder

    • Authors: Misir, Emre; Alptekin, Koksal

    • Year: 2020

 

Conclusion 🌟

Dr. MISIR’s career embodies a commitment to merging clinical expertise with neuroscience research to enhance the understanding and treatment of psychiatric disorders. His contributions to academia, professional organizations, and clinical practice solidify his role as an influential figure in modern psychiatry. As he continues to explore the intricate mechanisms of mental health, his work promises to shape the future of psychiatric care and inspire the next generation of researchers and clinicians. His journey is one of excellence, innovation, and unwavering dedication to mental health and neuroscience.

Shilin Luo | Neurogenetics and Molecular Neuroscience | Best Researcher Award

Prof. Shilin Luo | Neurogenetics and Molecular Neuroscience | Best Researcher Award

Prof. Shilin Luo, Xiangya Hospital, Central South University, China.

Dr. Shilin Luo is a leading expert in neuropharmacology and medicinal chemistry, with a strong academic background in traditional Chinese medicine and modern pharmacology. His research focuses on the pathogenesis of neurodegenerative diseases and the development of innovative drug therapies. Through his work at Xiangya Hospital, Central South University, and previous research at Emory University, he has made significant contributions to understanding neurological disorders. His studies on animal models and risk genes have paved the way for novel treatment strategies, earning him international recognition.

Profile

Scopus

Orcid

 

🎓 Early Academic Pursuits

Dr. Shilin Luo’s journey into the world of medical science began with a deep-rooted passion for understanding the complexities of neurological diseases. He earned his Bachelor’s degree in Chinese Materia Medica from Shenyang Pharmaceutical University, where he developed a strong foundation in traditional Chinese medicine and pharmacology. With an insatiable thirst for knowledge, he further pursued a Ph.D. in Medicinal Chemistry at China Pharmaceutical University, specializing in the research of active ingredients in natural products. Under the mentorship of Prof. Wencai Ye, a distinguished scholar, Dr. Luo honed his expertise in medicinal chemistry, paving the way for groundbreaking discoveries in neuropharmacology.

👨‍🎓 Professional Endeavors

To deepen his expertise, Dr. Luo embarked on postdoctoral research at Emory University’s School of Medicine in the Department of Pathology and Laboratory Medicine. Working under the esteemed Prof. Keqiang Ye, he focused on neurobiology and neuropharmacology, contributing significantly to the understanding of neurodegenerative diseases. His research provided novel insights into the molecular mechanisms underlying neurological disorders, positioning him as a leading figure in the field. He later took on a pivotal role as a professor in the Department of Neurology at Xiangya Hospital, Central South University, where he continues to mentor young scientists and advance medical research.

🧪 Contributions and Research Focus

Dr. Luo’s research is primarily dedicated to uncovering the pathogenesis of neurodegenerative diseases and developing therapeutic interventions. His work in animal models of pathogenic and risk genes for neurological disorders has been instrumental in identifying potential drug targets. By integrating traditional Chinese medicine with modern pharmacology, he has contributed to the development of innovative neuroprotective agents. His studies on the molecular mechanisms of neuronal degeneration have led to promising advancements in combating conditions such as Alzheimer’s and Parkinson’s disease.

🏆 Accolades and Recognition

Throughout his career, Dr. Luo has been widely recognized for his groundbreaking contributions to neuropharmacology. His research has been published in high-impact scientific journals, earning him international acclaim. His dedication to scientific excellence has garnered prestigious awards, and he is frequently invited to deliver keynote lectures at global conferences. His work continues to inspire fellow researchers, solidifying his reputation as a distinguished scientist in neurological drug development.

🏰 Impact and Influence

Dr. Luo’s impact extends beyond the laboratory, as he actively contributes to the medical community through mentorship and collaboration. His efforts in integrating traditional Chinese medicinal principles with cutting-edge pharmacological approaches have opened new avenues for drug discovery. His research findings have not only influenced academic discourse but have also laid the groundwork for potential clinical applications, bringing hope to patients suffering from neurodegenerative diseases.

⚛️ Legacy and Future Contributions

As a visionary scientist, Dr. Luo continues to push the boundaries of neurological research. His commitment to translational medicine aims to bridge the gap between laboratory discoveries and clinical applications. By fostering interdisciplinary collaborations and mentoring the next generation of researchers, he is shaping the future of neuropharmacology.

 

Publication

  • Disease-modifying therapies for Alzheimer’s disease: Clinical trial progress and opportunity
    Authors: Yujie Zhang, Jie Chen, Yanru Li, Bin Jiao, Shilin Luo
    Year: 2025

 

  • The role of the probiotic Akkermansia muciniphila in brain functions: insights underpinning therapeutic potential
    Authors: Ruiling Xu, Yuxuan Zhang, Shurui Chen, Yaohui Zeng, Xuan Fu, Ti Chen, Shilin Luo, Xiaojie Zhang
    Year: 2023

 

  • Nonviral delivery systems for antisense oligonucleotide therapeutics
    Authors: Si Huang, Xin-Yan Hao, Yong-Jiang Li, Jun‑Yong Wu, Da-Xiong Xiang, Shilin Luo
    Year: 2022

 

  • The Microglial membrane receptor TREM2 mediates exosome secretion to promote phagocytosis of amyloid‐β by microglia
    Authors: Si Huang, Xiaoli Liao, Junyong Wu, Xiaojie Zhang, Yamin Li, Daxiong Xiang, Shilin Luo
    Year: 2022

 

  • Correction: Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamine
    Authors: Not explicitly listed
    Year: 2021

 

  • Polygonatum sibiricum Polysaccharides Protect against MPP‐Induced Neurotoxicity via the Akt/mTOR and Nrf2 Pathways
    Authors: Si Huang, Haiyan Yuan, Wenqun Li, Xinyi Liu, Xiaojie Zhang, Daxiong Xiang, Shilin Luo, Guodong Zhang
    Year: 2021

 

  • Bushen-Tiansui Formula Improves Cognitive Functions in an Aβ1–42 Fibril-Infused Rat Model of Alzheimer’s Disease
    Authors: Chenxia Sheng, Panpan Xu, Xinyi Liu, Weijun Peng, Daxiong Xiang, Shilin Luo
    Year: 2020

 

  • Osteogenesis activity of isocoumarin a through the activation of the PI3K-Akt/Erk cascade-activated BMP/RUNX2 signaling pathway
    Authors: Not explicitly listed
    Year: 2019

 

  • Akt Phosphorylates NQO1 and Triggers its Degradation, Abolishing Its Antioxidative Activities in Parkinson’s Disease
    Authors: Shilin Luo, Seong Su Kang, Zhi-Hao Wang, Xia Liu, Julia X Day, Zhiping Wu, Junmin Peng, Daxiong Xiang, Wolfdieter Springer, Keqiang Ye
    Year: 2019

 

  • Puerarin-loaded PEG-PE micelles with enhanced anti-apoptotic effect and better pharmacokinetic profile
    Authors: Not explicitly listed
    Year: 2018

 

Conclusion

Dr. Luo’s unwavering dedication to neurological research continues to shape the future of neuropharmacology. His innovative approach, combining traditional medicinal insights with modern scientific advancements, has the potential to revolutionize drug development for neurodegenerative diseases. As a mentor, researcher, and pioneer in his field, his contributions will leave a lasting impact on both academia and clinical medicine, offering hope for more effective treatments in the years to come.

 

Ali Mehri | Neuroscience | Neuroscience Research Pioneer Award

Dr. Ali Mehri | Neuroscience | Neuroscience Research Pioneer Award

Dr. Ali Mehri Babol, Noshirvani University of Technology, Iran.

Dr. Ali Mehri is a prominent physicist whose academic journey has bridged the fields of solid-state physics, data science, and complex systems. With a Ph.D. in Solid State Physics from the University of Zanjan, his research explores novel interdisciplinary areas such as text mining, complex networks, and thermal and electronic transport in nanostructures. His work, particularly in the application of physical principles to data mining and linguistic studies, has significantly contributed to both theoretical and applied physics. Additionally, his research on the statistical properties of irrational numbers and the connection between Zipf’s exponent and language distribution has broadened the scope of complex systems analysis.

Profile

Google Scholar

Early Academic Pursuits 🎓

Dr. Ali Mehri began his academic journey in physics with a focus on solid-state physics. He completed his Bachelor’s degree in Solid State Physics at Kharazmi University in Tehran, Iran, in 2002. His passion for condensed matter physics led him to pursue a Master’s degree at the Institute for Advanced Studies in Basic Sciences (IASBS), Zanjan, where he focused on colloidal monolayers in the presence of periodic light fields. Under the guidance of Professor Mir Faez Miri, he laid the foundation for his future research. In 2008, Dr. Mehri earned his Ph.D. in Solid State Physics from the University of Zanjan, where he studied the role of entropy in text mining under the supervision of Professor Amir Hossein Darooneh. This pivotal research provided him with a unique perspective that blends physics with data science.

Professional Endeavors 💼

After completing his education, Dr. Mehri embarked on a career in academia, where he has established himself as a dedicated educator and researcher. He currently serves as a faculty member at the Department of Physics, Babol Noshirvani University of Technology. His professional journey is marked by his deep involvement in research, teaching, and mentoring students, particularly in the fields of data and text mining, complex networks theory, and nanostructures. Over the years, he has collaborated with various national and international researchers, enhancing the global visibility of his work in these specialized areas of study.

Contributions and Research Focus 🔬

Dr. Mehri’s research interests lie at the intersection of physics and data science. His work on text mining using the Hurst exponent is a significant contribution to the emerging field of applying physical principles to analyze textual data. He has also explored the intriguing topic of irrational numbers by studying statistical distances to determine the order of digits. Furthermore, Dr. Mehri’s research extends to the correlation between Zipf’s exponent and the geographical distribution of human languages, which connects his expertise in complex networks theory with linguistics. His exploration of thermal and electronic transport in nanostructures adds a solid foundation to his contributions in condensed matter physics.

Accolades and Recognition 🏅

Throughout his academic career, Dr. Ali Mehri has received numerous accolades for his research contributions. His work, particularly in data mining and complex networks, has earned him recognition both in Iran and internationally. Dr. Mehri’s research has been cited in various scientific journals, showcasing the relevance and impact of his work in advancing knowledge within his fields. His academic achievements have solidified his reputation as a forward-thinking physicist who bridges the gap between theoretical and applied sciences.

Impact and Influence 🌍

Dr. Mehri’s work has had a profound impact on various scientific communities, particularly in the fields of data mining, complex networks, and nanostructures. By introducing concepts like the Hurst exponent to text mining and exploring the relationships between statistical distances and irrational numbers, his research has influenced not only physics but also the interdisciplinary applications of data science. His contributions to understanding the connection between language distribution and Zipf’s law have opened new avenues for researchers in both physics and linguistics, highlighting the diverse impact of his work across disciplines.

Legacy and Future Contributions 🕰️

As Dr. Mehri continues to push the boundaries of research, his legacy will be defined by his ability to merge complex concepts from physics with innovative methodologies from data science. His future contributions are expected to further enhance the understanding of nanostructures, electronic transport, and complex systems. Moreover, his pioneering work in text mining and the analysis of irrational numbers has the potential to lead to groundbreaking advancements in computational physics and data analytics. As his research evolves, Dr. Mehri’s work will undoubtedly inspire future generations of physicists and data scientists, reinforcing his lasting influence in these fields.

Publication

  • Title: The complex networks approach for authorship attribution of books
    Authors: A Mehri, AH Darooneh, A Shariati
    Year: 2012

 

  • Title: Variation of Zipf’s exponent in one hundred live languages: A study of the Holy Bible translations
    Authors: A Mehri, M Jamaati
    Year: 2017

 

  • Title: A nonextensive modification of the Gutenberg–Richter law: q-stretched exponential form
    Authors: AH Darooneh, A Mehri
    Year: 2010

 

  • Title: Word ranking in a single document by Jensen–Shannon divergence
    Authors: A Mehri, M Jamaati, H Mehri
    Year: 2015

 

  • Title: The role of entropy in word ranking
    Authors: A Mehri, AH Darooneh
    Year: 2011

 

  • Title: Keyword extraction by nonextensivity measure
    Authors: A Mehri, AH Darooneh
    Year: 2011

 

  • Title: Tsallis entropy, escort probability and the incomplete information theory
    Authors: AH Darooneh, G Naeimi, A Mehri, P Sadeghi
    Year: 2010

 

  • Title: Text mining by Tsallis entropy
    Authors: M Jamaati, A Mehri
    Year: 2018

 

  • Title: Power-law regularities in human language
    Authors: A Mehri, SM Lashkari
    Year: 2016

 

  • Title: Non-extensive distribution of human eye photoreceptors
    Authors: A Mehri
    Year: 2017

 

Conclusion

Dr. Mehri’s professional career, marked by teaching and research at Babol Noshirvani University of Technology, has earned him national and international recognition. His research continues to influence fields as diverse as data science, linguistics, and condensed matter physics. Looking ahead, his work promises to advance the understanding of nanostructures and foster the further integration of physics with computational and data sciences. Dr. Mehri’s legacy will likely continue to inspire future generations of scientists, underscoring the importance of interdisciplinary collaboration in driving scientific progress.

Alytia Levendosky | Behavioral Neuroscience | Best Researcher Award

Dr. Alytia Levendosky | Behavioral Neuroscience | Best Researcher Award

Dr. Alytia Levendosky, Michigan State University, United States.

Alytia Akiko Levendosky’s academic journey began with a strong foundation in Biological Anthropology at Harvard-Radcliffe College, where she graduated Magna Cum Laude. Her passion for understanding the complexities of human behavior led her to pursue advanced studies in Clinical Psychology at the University of Michigan, culminating in a Ph.D. in 1995. As a professor at Michigan State University, she has excelled in research and teaching, making significant contributions to the study of mental health, developmental psychology, and human behavior. Her work reflects a balance of intellectual rigor, compassion, and a dedication to advancing the field.

Profile

Google Scholar

Scopus

🌱 Early Academic Pursuits

Alytia Akiko Levendosky began her remarkable academic journey at Harvard-Radcliffe College, where she pursued a Bachelor of Arts in Biological Anthropology, graduating Magna Cum Laude in 1987. Her early fascination with the biological and psychological dimensions of human behavior laid a strong foundation for her future endeavors. Harvard’s intellectually vibrant environment nurtured her curiosity, sparking a lifelong passion for understanding human development and mental health.

🎓 Professional Endeavors in Psychology

After completing her undergraduate studies, Alytia delved deeper into the field of psychology at the University of Michigan, earning her Master’s degree in Clinical Psychology in 1992 and a Ph.D. in 1995. Her doctoral work showcased her commitment to unraveling the complexities of clinical psychology, marking her as a rising star in the discipline. As a faculty member in the Department of Psychology at Michigan State University, she dedicated herself to advancing both research and teaching. Her contributions to the academic community have made her an influential figure in the field.

🧠 Contributions to Research and Understanding

Alytia’s research has primarily focused on clinical psychology, with a particular interest in the interaction between biological and psychological factors in human behavior. Through her work, she has contributed significant insights into mental health, developmental psychology, and behavioral patterns. Her scholarly pursuits reflect a balance of rigorous scientific inquiry and a compassionate understanding of the human condition.

🌟 Accolades and Recognition

Throughout her academic career, Alytia has been celebrated for her intellectual contributions and dedication to teaching. Her ability to inspire students and colleagues alike has earned her a place of respect and admiration in the academic world. Her research achievements and the success of her students speak volumes about her influence as an educator and mentor.

🌍 Impact on Mental Health and Human Development

Alytia’s work has had a profound impact on the study of mental health and human development. By integrating clinical practices with research, she has advanced the understanding of complex psychological phenomena, contributing to improved therapeutic approaches. Her dedication to fostering a deeper comprehension of mental well-being has resonated far beyond the classroom and the research lab.

🔑 Legacy of Knowledge and Insight

Alytia’s enduring legacy lies in her commitment to pushing the boundaries of knowledge in psychology. Her intellectual rigor and empathetic perspective have left an indelible mark on her students, colleagues, and the broader psychological community. The ripple effects of her work continue to influence future generations of psychologists and researchers.

🚀 Future Contributions to Psychology

With her rich background in clinical psychology and her passion for research, Alytia remains poised to make further contributions to the field. Her ongoing efforts to bridge gaps in understanding human behavior promise to drive new discoveries and inspire meaningful progress in mental health care and psychological research.

 

Publications

  • Parenting in battered women: The effects of domestic violence on women and their children
    Authors: AA Levendosky, SA Graham-Bermann
    Year: 2001

 

  • The impact of domestic violence on the maternal-child relationship and preschool-age children’s functioning
    Authors: AA Levendosky, AC Huth-Bocks, DL Shapiro, MA Semel
    Year: 2003

 

  • Resilience among children exposed to domestic violence: The role of risk and protective factors
    Authors: C Martinez-Torteya, G Anne Bogat, A Von Eye, AA Levendosky
    Year: 2009

 

  • Traumatic stress symptoms in children of battered women
    Authors: SA Graham-Bermann, AA Levendosky
    Year: 1998

 

  • Phase-shifting effects of bright morning light as treatment for delayed sleep phase syndrome
    Authors: NE Rosenthal, JR Joseph-Vanderpool, AA Levendosky, SH Johnston, …
    Year: 1990

 

  • Trauma symptoms among infants exposed to intimate partner violence
    Authors: GA Bogat, E DeJonghe, AA Levendosky, WS Davidson, A Von Eye
    Year: 2006

 

  • Domestic violence, maternal parenting, maternal mental health, and infant externalizing behavior
    Authors: AA Levendosky, KL Leahy, GA Bogat, WS Davidson, A Von Eye
    Year: 2006

 

  • Trauma symptoms in preschool-age children exposed to domestic violence
    Authors: AA Levendosky, AC Huth-Bocks, MA Semel, DL Shapiro
    Year: 2002

 

  • Adolescent survivors of childhood sexual abuse: The mediating role of attachment style and coping in psychological and interpersonal functioning
    Authors: DL Shapiro, AA Levendosky
    Year: 1999

 

  • The direct and indirect effects of domestic violence on young children’s intellectual functioning
    Authors: AC Huth-Bocks, AA Levendosky, MA Semel
    Year: 2001

 

🌟 Conclusion

Alytia’s career is a testament to her profound commitment to unraveling the complexities of the human mind and fostering mental well-being. Through her research, teaching, and mentorship, she has inspired countless students and peers, leaving a lasting impact on the field of psychology. As she continues her journey, her contributions promise to shape the future of psychological research, ensuring that her legacy will endure for generations to come.